Acceptance of the HPV Vaccine for Adolescent Girls: Analysis of State-Added Questions from the BRFSS

Markey Cancer Control Program, University of Kentucky, Lexington, Kentucky 40504-3381, USA.
Journal of Adolescent Health (Impact Factor: 3.61). 06/2009; 44(5):437-45. DOI: 10.1016/j.jadohealth.2008.09.001
Source: PubMed


Previous research regarding human papillomavirus (HPV) awareness and vaccine acceptance has relied on convenience or other selected samples of the population. To assess the prevalence of HPV awareness and vaccine acceptance in Kentucky we added questions to the 2006 Kentucky Behavioral Risk Factor Survey System (BRFSS), a population-based survey of health behaviors.
Women who participated in the statewide BRFSS were asked two HPV-related questions: one assessed previous awareness of HPV, and another assessed vaccine acceptance for girls 10 to 15 years old. We used crosstabulations and multivariate logistic regression to determine which factors were associated with HPV awareness and vaccine acceptance. Because the HPV vaccine Gardasil was approved in June 2006, we conducted an analysis of pre- and postapproval HPV awareness and vaccine acceptance. We also compared results across Appalachian and non-Appalachian counties, two distinct regions of Kentucky.
Overall, 57.6% of women had heard of HPV, and 70.2% accepted vaccination for girls. HPV awareness increased after Gardasil's approval, but the increase was much smaller among Appalachian women. Prevalence of vaccine acceptance was unchanged in both regions. Awareness of HPV was not associated with vaccine acceptance, and factors significantly associated with vaccine acceptance in multivariate analysis differed by Appalachian status.
This population-based survey of Kentucky women found relatively high vaccine acceptance for girls. Also, many respondents reported not knowing whether they accept vaccination, and factors associated with vaccine acceptance varied by Appalachian status. These findings suggest that acceptance of the HPV vaccine for girls may improve with targeted interventions.

Download full-text


Available from: W. Jay Christian, Aug 07, 2014
1 Follower
53 Reads
  • Source
    • "vaccine (Gardasil) and bivalent vaccine (Cevarix). In June 2006, after the US Food and Drug Administration licensed, these vaccines have been recommended for girls between the ages of 9-26 in many European countries, in New Zealand, Australia, and in the USA within the context of various school immunization programs (Markowitz et al., 2007; Christian et al., 2009; Weisberg et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human papilloma virus (HPV) is one of the most common sexually transmitted agents and its infection is the most established cause of cervical cancer. Midwives play a key position in the implementation of cervical cancer. This descriptive study aimed to determine the level of knowledge concerning HPV and HPV vaccination among 268 midwifery students. Data were collected between November 15 and 30, 2011, through a self-reported questionnaire. The mean age of participants was 20.75±1.60. Among all students, 44.4% had heard of HPV, while 40.4% had heard of HPV vaccinatiob. The relationship between the midwifery student knowledge on HPV and HPV vaccine and their current educational year was significant (p=0.001). In conclusion midwifery students have moderate level of knowledge about HPV and its vaccine and relevant information should be included in their teaching curriculum.
    Asian Pacific journal of cancer prevention: APJCP 11/2013; 14(11):6775-8. DOI:10.7314/APJCP.2013.14.11.6775 · 2.51 Impact Factor
  • Source
    • "This study found that awareness of HPV ( 26% ) and HPV vaccine ( 21 . 7% ) were low in comparison to previous studies which reported higher rate of awareness ranged from 57 . 6% to 84 . 3% ( Jain et al . , 2009 and Christian et al . , 2009 ) . However , low level of knowledge was found by some previous studies from Malaysia ( Wong , 2008 ) and other countries ( Giles & Garland , 2006 ; Moreira et al . , 2006 ; Donders et al . , 2008 ; Vanslyke et al . , 2008 ) . For example , a study in Norway showed that only 20% of women had heard about HPV ( Kahn et al . , 2003 ) . Len"
    [Show abstract] [Hide abstract]
    ABSTRACT: A cross-sectional study was conducted among 300 Malaysian women in the obstetrics and gynecology outpatient clinic in a selected hospital in Bangi, Selangor to determine the level of knowledge of HPV and HPV vaccines, attitudes toward HPV vaccination and barriers of being vaccinated. Factors associated with knowledge and attitudes were also addressed with a questionnaire. Seventy eight women (26%) had heard about the HPV virus and 65 about HPV vaccines (21.7%). Marital status was associated significantly with awareness of HPV and HPV vaccine (p=0.002, p=0.002; respectively), in addition to level of education (p=0.042). The percentages of women who reported correct answers for the questions on knowledge of HPV and HPV vaccine ranged from 12% to 25%. One hundred fifty nine respondents (53%) had a positive attitude toward HPV vaccination. Age, marital status, and level of education were associated significantly with attitude (p<0.001, p<0.001, p=0.002; respectively). The most important barriers reported were 'unawareness of the vaccine' 'concerned about side effects' and 'afraid of needles'. This study found a very low level of knowledge of HPV and HPV vaccine. Education of population is highly recommended and barriers to being vaccinated should be dealt with seriously.
    Asian Pacific journal of cancer prevention: APJCP 01/2010; 11(4):887-92. · 2.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the prevalence and predictors of human papillomavirus (HPV) vaccination in adolescent girls who were recommended to receive the vaccine by their health care providers. Cross-sectional study. United States in 2007-08. Parents or guardians most knowledgeable about health and health care of adolescent girls aged 12 to 17 years participating in the 2007 National Survey of Children's Health (NSCH). NCSH was a population-based telephone survey using a complex probability sampling design. Prevalence of HPV vaccination in adolescent girls who were recommended to receive the HPV vaccine and predisposing, enabling, and need factors associated with HPV vaccination. Of 12.38 million adolescent girls aged 12 to 17 years, 3.69 million (29.76%) were recommended to receive the HPV vaccine by their health care provider. The majority who received the HPV vaccine recommendation were 13 to 17 years of age (83%), were white (71%), and had one or more preventive visits (94%). Among those for whom the HPV vaccine was recommended, 48.75% (95% CI 45.37-52.13) received the vaccine. Multivariate logistic regression analysis of those who were recommended revealed that enabling and predisposing factors were significantly associated with the HPV vaccination. Children living at 101% to 200% of the Federal Poverty Level (odds ratio 0.54 [95% CI 0.30-0.98]) and children in households with two or more adults (0.51 [0.33-0.80]) were negatively associated with HPV vaccination, whereas children with any preventive medical care visit(s) (2.28 [1.36-3.84]) in the previous year were positively associated with HPV vaccination. Nearly one-half of adolescent girls received the HPV vaccine among those who were recommended by their health care provider. The study finding emphasizes the importance of predisposing and enabling factors for HPV vaccination. Policy and education efforts can focus on these factors to improve HPV vaccination rates.
    Journal of the American Pharmacists Association 01/2012; 52(1):52-8. DOI:10.1331/JAPhA.2012.10195 · 1.24 Impact Factor
Show more